Evidence map›Paper›PMID 25405730›Full record

ReviewInternational journal of molecular sciences2014

Stem cells: the pursuit of genomic stability.

Saranya P Wyles, Emma B Brandt, Timothy J Nelson

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. DPPA5A suppresses the mutagenic TLS and MMEJ pathways by modulating the cryptic splicing ofProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  4. Science advances · 2023
    Article
  5. Science advances · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. A Tale of Two States: Pluripotency Regulation of Telomeres.Frontiers in cell and developmental biology · 2021
    Review
  10. Review
  11. Cellular Reprogramming-A Model for Melanoma Cellular Plasticity.International journal of molecular sciences · 2020
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Saranya P WylesCenter for Regenerative Medicine, Mayo Clinic, Rochester, MN 55901, USA. wyles.saranya@mayo.edu.
Emma B BrandtCenter for Regenerative Medicine, Mayo Clinic, Rochester, MN 55901, USA. brandt.emma@mayo.edu.
Timothy J NelsonCenter for Regenerative Medicine, Mayo Clinic, Rochester, MN 55901, USA. nelson.timothy@mayo.edu.
WinnMed · USMayo Clinic · US

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
Medical Scientist Traning Program at Mayo ClinicT32GM065841 · NIGMS · MAYO CLINIC ROCHESTER · PI KAUFMANN, SCOTT H, SCHIMMENTI, LISA A · 2003 to 2022
$5.8M
Dysfunctional regeneration in cardiomyopathy: iPS-based diagnosis and therapyDP2OD007015 · OD · MAYO CLINIC ROCHESTER · PI NELSON, TIMOTHY JAMES · 2010 to 2010
$2.4M
NCATS NIH HHS UL1 TR000135NIGMS NIH HHS T32 GM065841NIGMS NIH HHS T32 GM 65841NIH HHS DP2 OD007015NIH HHS OD007015-01
6 · The paper itself

Abstract

Stem cells harbor significant potential for regenerative medicine as well as basic and clinical translational research. Prior to harnessing their reparative nature for degenerative diseases, concerns regarding their genetic integrity and mutation acquisition need to be addressed. Here we review pluripotent and multipotent stem cell response to DNA damage including differences in DNA repair kinetics, specific repair pathways (homologous recombination vs. non-homologous end joining), and apoptotic sensitivity. We also describe DNA damage and repair strategies during reprogramming and discuss potential genotoxic agents that can reduce the inherent risk for teratoma formation and mutation accumulation. Ensuring genomic stability in stem cell lines is required to achieve the quality control standards for safe clinical application.

Indexed as

Genomic InstabilityAnimalsApoptosisCellular ReprogrammingDNA DamageDNA RepairHumansInduced Pluripotent Stem CellsMultipotent Stem CellsPluripotent Stem CellsStem Cells

Identifiers

PMID25405730
PMCPMC4264205
OpenAlexW2083626880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.